Quantcast Nonbarbiturate sedative and hypnotics - Pharmacology I

Share on Google+Share on FacebookShare on LinkedInShare on TwitterShare on DiggShare on Stumble Upon
Custom Search
 
  
 
c.
Intermediate-Acting Barbiturates.
(1)  Basic information. Intermediate-acting barbiturates have a duration of
action that lasts from 4 hours to 6 hours. These agents are mainly use for the initial and
short-term treatment of insomnia.
Example of intermediate-acting barbiturate. Amobarbital (Amytal).
(2)
d.
Long-Acting Barbiturates.
(1)  Basic information. Long-acting barbiturates have a duration of action
that lasts from 6 hours to 8 hours. These agents are used orally to maintain daylong
sedation in anxiety-tension states. Furthermore, long-acting barbiturates are useful in
the treatment of various convulsive disorders.
(2)
Examples of long-acting barbiturates.
(a)
Phenobarbital.
Mephobarbital (Mebaral).
(b)
7-9. NONBARBITURATE SEDATIVES AND HYPNOTICS
a.
Short-Acting Agents.
(1)  Background information. Short-acting nonbarbiturate sedative-hypnotics
are generally used orally in the initial and short-term treatment of insomnia.
(2)
Examples of short-acting nonbarbiturate sedative-hypnotics.
(a)  Chloral hydrate (Noctec). Drug interactions may occur between
chloral hydrate and anticoagulants, furosemide, alcohol, or other drugs that are CNS
depressants.
(b)  Triazolam (Halcion). Triazolam is rapidly absorbed through the
oral route and is as effective as the barbiturates in inducing sleep. It is excreted in
breast milk and should not be administered to nursing mothers.
b.
Intermediate-Acting Agents.
(1)  Background information. Intermediate-acting nonbarbiturate agents are
administered orally to effectively control moderate to severe daytime anxiety and
tension in patients who have neuroses and mild depressive states.
(2)
Examples of intermediate-acting nonbarbiturates.
MD0804
7-8



Medical News
Sofosbuvir/daclatasvir combination effective treatment for difficult-to-treat hep C patients
Results presented today at The International Liver Congress 2015 show...
medicalxpress.com
DCV, SOF and RBV combination effective / tolerated in HCV with adv, cirrhosis / post-transplant recurrence
Phase 3 results presented today at The International Liver Congress...
medicalxpress.com
Use of direct-antiviral agents helps overcome hepatitis C recurrence in liver transplant patients
New data presented today at The International Liver Congress 2015,...
medicalxpress.com
Sofosbuvir plus peginterferon/ribavirin demonstrates virologic response rates in G3 hep C patients
Results presented today at The International Liver Congress 2015 demonstrate...
medicalxpress.com
Alcohol use disorders - stronger predictor of mortality than chronic hepatitis C virus infection
Results presented today at The International Liver Congress 2015, show...
medicalxpress.com
Hepatitis C screening essential to help catch patients with advanced liver fibrosis
Study results presented today at The International Liver Congress 2015...
medicalxpress.com
MRI shows association between reading to young children and brain activity
Among the advice new parents receive is to read to...
medicalxpress.com
Giving books to kids before summer break can stem reading losses
It's common knowledge among teachers that when students return to...
medicalxpress.com
State laws dampen texting by teen drivers but rates still high
State laws banning texting while driving led to significant reductions...
medicalxpress.com
Youths who survive self-poisoning continue to be at risk of suicide for years
Teenagers who are hospitalized after intentionally poisoning themselves are at...
medicalxpress.com
Magazine, Internet images fail to promote infant sleep safety
Images of infants sleeping in unsafe environments are pervasive in...
medicalxpress.com
Researchers highlight need for better evidence to guide EU efforts to increase hep B+C testing
The apparent dearth of research on hepatitis B and C...
medicalxpress.com
Preliminary safety findings: IFN-free DAA comb. with dasabuvir in chronic HCV patients
Preliminary data from an ongoing study revealed today at The...
medicalxpress.com
Use of pocket-sized ultrasound device reduces need for further testing in clinical settings
Results from a study presented today at The International Liver...
medicalxpress.com
West Africa battles mystery of 'post-Ebola syndrome'
As the Ebola epidemic retreats across west Africa, international health...
medicalxpress.com
Babies as young as 6 months using mobile media
More than one-third of babies are tapping on smartphones and...
medicalxpress.com
Drinking just 1 or 2 alcoholic drinks a day linked to liver disease
According to the World Health Organization, excessive alcohol drinking is...
medicalxpress.com
Cell phones take parents' attention away from kids on playgrounds
Parents who take their kids to the playground may be...
medicalxpress.com
Hawaii poised to become first state to raise smoking age to 21
Lawmakers have passed a bill that would make Hawaii the...
medicalxpress.com
Pepsi dropping sweetener aspartame from diet cola drinks
PepsiCo said Friday it was bowing to customer demand and...
medicalxpress.com
 


Privacy Statement - Copyright Information. - Contact Us

comments powered by Disqus

Integrated Publishing, Inc.
9438 US Hwy 19N #311 Port Richey, FL 34668

Phone For Parts Inquiries: (727) 755-3260
Google +